Dermatitis during efalizumab treatment in a patient with psoriasis vulgaris

Br J Dermatol. 2005 Oct;153(4):843-4. doi: 10.1111/j.1365-2133.2005.06840.x.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antibodies, Monoclonal / adverse effects*
  • Antibodies, Monoclonal, Humanized
  • CD11a Antigen / immunology
  • Dermatologic Agents / adverse effects*
  • Drug Eruptions / etiology*
  • Drug Eruptions / pathology
  • Humans
  • Male
  • Middle Aged
  • Psoriasis / drug therapy*
  • Psoriasis / pathology

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • CD11a Antigen
  • Dermatologic Agents
  • efalizumab